Search

You searched for "prostate"

476 results found

Prostate cancer: Black men more likely to be diagnosed at later stages

9 January 2025 | Charities, Research & Development
Latest data shows Black men have higher rates of stage 3 or stage 4 prostate cancer diagnoses compared with white men. Black men diagnosed at a later stage in their 60s are 14% less likely to get NICE approved treatment...

BXTAccelyon becomes global distribution partner for new online prostate MRI self-learning tool to enhance prostate cancer diagnosis

6 May 2020 | Contracts & Distributors
BXTAccelyon, the leading low dose rate (LDR) brachytherapy partner to hospitals and clinics worldwide, and distribution partner for PrecisionPoint™, the...

Prostate Scotland Robotic Training, Fellowship, Clinical Visit & Research Awards

17 September 2024 | Research & Development, Awards, Conferences & Anniversaries, Charities
Prostate Scotland, in association with The Urology Foundation, has a number of awards available to support the training of urologists, surgery nurses and first surgical assistants in Scotland in robotic assisted prostate cancer surgery. The awards – ranging in value...

Fusion Bx 2.0 targeted prostate biopsy solution receives CE Mark

4 November 2019 | Research & Development
Focal Healthcare, an innovator of image-guided prostate cancer technology, has received CE Mark for its Fusion BxTM 2.0 prostate fusion biopsy solution.

EAU (European Association of Urology) Masterclass on Focal therapy for localised prostate cancer

5 December 2024 -6 December 2024
Focal Therapy (FT) is a promising treatment option aimed at improving the management of localised prostate cancer. This masterclass will provide you with an extensive review of the rationale for FT, the patient selection modalities and the available energy sources (HIFU, Cryo, IRE, Laser, Brachytherapy). Gain further knowledge and better understand the FT benefits.

APCCC (Advanced Prostate Cancer Consensus Conference) Diagnostics 2025

27 February 2025 -28 February 2025
The diagnostic abilities for assessing prostate cancer patients have significantly evolved in the last years. Ranging from advanced imaging modalities for detection, new innovative liquid and tissue based biomarkers as well as the recent introduction of PSMA PET imaging have significantly advanced the field, challenging some of the old grounds of truth.

Prostate Cancer UK: Specialist Education Conference 2025 (Free)

26 March 2025 -27 March 2025
You’ll hear from a panel of expert speakers who’ll share their knowledge and best practice guidance about prostate cancer care. They’ll provide the latest information and guidance, helping you to provide best practice care for your patients. You’ll also cover CPD requirements by attending. From 9am - 12 noon.

Announcing a new specialist distributor of medical devices for prostate cancer

10 January 2022 | Contracts & Distributors, Research & Development
Healthcare Supply Solutions are a new distributor focussed on medical devices for the diagnosis and management of Prostate Cancer.

Prostate Cancer UK: Towards Equity: Exploring Prostate Cancer Disparities Experienced by Black Men - data and evidence mini conference (Free)

13 March 2025
We will delve into why Prostate Cancer UK is exploring health inequalities, starting with Black men and highlight valuable research findings and challenges in health inequalities space, with keynote speaker Dr Tom Cowling, who will share his insights from the latest England and Wales NPCA State of the Nation Report, including sociodemographic and tumour data from England. From 1.30 pm - 4.30pm

FUJIFILM Healthcare Europe launches a dedicated prostate fusion imaging platform

8 July 2022 | Research & Development
FUJIFILM Healthcare Europe is pleased to have unveiled the ARIETTA™ 65 IntuitiveFusion.

Prostate Cancer UK announced as official charity partner for MOBO Awards

6 February 2025 | Awards, Conferences & Anniversaries
The stage is set! Global dancehall queen Spice, UK rap kings Krept and Konan and the multi-talented Bashy are the first wave of performers announced to ignite the stage at the 2025 MOBO Awards.

The Royal Marsden: Demystifying the Science Behind Targeted Treatments and Immunotherapies for Prostate, Bladder & Kidney Cancers Study Day

14 March 2025
Dr Elaine Vickers will provide an introduction to the science behind a wide variety of targeted therapies and immunotherapies given to people with prostate, bladder and kidney cancer.